The medical management of depression

N Engl J Med. 2005 Oct 27;353(17):1819-34. doi: 10.1056/NEJMra050730.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adrenergic Uptake Inhibitors / therapeutic use
  • Algorithms
  • Anticonvulsants / therapeutic use
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use*
  • Antipsychotic Agents / therapeutic use
  • Bipolar Disorder / drug therapy
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / drug therapy*
  • Depressive Disorder, Major / genetics
  • Drug Monitoring
  • Humans
  • Membrane Glycoproteins / genetics
  • Membrane Transport Proteins / genetics
  • Nerve Tissue Proteins / genetics
  • Neurons / drug effects
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Uptake Inhibitors / therapeutic use*

Substances

  • Adrenergic Uptake Inhibitors
  • Anticonvulsants
  • Antidepressive Agents
  • Antipsychotic Agents
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • SLC6A4 protein, human
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Uptake Inhibitors